Molecular docking of the highly hypolipidemic agent alpha-asarone with the catalytic portion of HMG-CoA reductase.
Medina-Franco JL, Lopez-Vallejo F, Rodriguez-Morales S, Castillo R, Chamorro G, Tamariz J, Bioorg Med Chem Lett, 2005 Feb 15 - link

Docking-based CoMFA and CoMSIA studies of non-nucleoside reverse transcriptase inhibitors of the pyridinone derivative type.
Medina-Franco JL, Rodriguez-Morales S, Juarez-Gordiano C, Hernandez-Campos A, Castillo R, J Comput Aided Mol Des, 2004 May - link

Flexible docking of pyridinone derivatives into the non-nucleoside inhibitor binding site of HIV-1 reverse transcriptase.
Medina-Franco JL, Rodriguez-Morales S, Juarez-Gordiano C, Hernandez-Campos A, Jimenez-Barbero J, Castillo R, Bioorg Med Chem, 2004 Dec 1 - link